ValGenesis | $16,000,000 | (Jul 23, 2025)
Capitalize.io | Undisclosed Amount | (Jul 23, 2025)
Phlow | $37,000,000 | (Jul 23, 2025)
Certified by Founder
Lodge
Brightstar Therapeutics
start up
United States
- Lexington, Kentucky
- 21/04/2023
- Series A
- Undisclosed Amount
Brightstar Therapeutics is a biotechnology company focused on providing innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases.
Brightstar Therapeutics is the first company to offer a long-term solution for persistent epithelial defects, and partial limbal stem cell deficiency through its advanced corneal allograft, BrightMEM.
- Industry Hospital & Health Care
- Website https://www.brightstartx.com/
- LinkedIn https://www.linkedin.com/company/brightstar-therapeutics/
Composio | $25,000,000 | (Jul 23, 2025)
Nevoya | $9,300,000 | (Jul 23, 2025)
Buena | $58,000,000 | (Jul 23, 2025)
Scrunch AI | $15,000,000 | (Jul 23, 2025)
Delve | $32,000,000 | (Jul 23, 2025)
CandorIQ | $4,800,000 | (Jul 23, 2025)
AbsoluteCare | $135,000,000 | (Jul 23, 2025)
BetterComp | $33,000,000 | (Jul 23, 2025)
Alix | $20,000,000 | (Jul 22, 2025)